lorundrostat

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionNCT05968430MLYSPhase 3Active not recruiting2025-12-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.